Cardiovascular and Metabolic Disorders

Featured Article

Maternal Deaths in the United States: Sounding a Call to Action

Maternal Deaths in the United States: Sounding a Call to Action

Despite multiple measures and goals to reduce US maternal mortality rates, the latest data suggest the United States is far behind the rest of the world in maternal health care.

Latest

Hypertension in Pregnancy: Are Antihypertensive Agents Safe?

Hypertension in Pregnancy: Are Antihypertensive Agents Safe?

According to Journal of the American Heart Association, pregnant women with chronic hypertension using antihypertensive agents reduces the risk of hypertension without added risk to the fetus.

FDA: Application Submitted for CV Safety Data Review of Insulin Degludec

FDA: Application Submitted for CV Safety Data Review of Insulin Degludec

The FDA is poised to review data from the DEVOTE trial, examining the rates of major adverse cardiovascular events in insulin degludec vs insulin glargine.

Metabolic Syndrome and Parkinson's Progression: Is There A Link?

Metabolic Syndrome and Parkinson's Progression: Is There A Link?

Patients with metabolic syndrome experienced an increase in Unified Parkinson's Disease Rating Scale (UPDRS) scores.

Maternal Overweight, Obesity Linked to Increase in Fetal Birth Defects

Maternal Overweight, Obesity Linked to Increase in Fetal Birth Defects

Researchers suggest that women with overweight or obesity aim to lose weight before becoming pregnant.

Serum Cholesterol Levels Over Time and Risk of Parkinson's Disease

Serum Cholesterol Levels Over Time and Risk of Parkinson's Disease

The role of cholesterol in Parkinson's disease is not well understood.

Extended-Release Naltrexone/Bupropion Efficacious for Weight Loss in Type 2 Diabetes

Extended-Release Naltrexone/Bupropion Efficacious for Weight Loss in Type 2 Diabetes

Two studies examined the effects of naltrexone/bupropion on weight loss, glycemic parameters, and cardiovascular risks in patients with type 2 diabetes.

Glycemic Control and Mortality Risk With Statins in Type 2 Diabetes

Glycemic Control and Mortality Risk With Statins in Type 2 Diabetes

Patients with type 2 diabetes taking statins after insulin initiation had better glycemic control, but their risk for mortality was higher compared with patients who did not take statins.

Orthostatic Hypotension In Type 2 Diabetes Increases CV, Cerebrovascular Events

Orthostatic Hypotension In Type 2 Diabetes Increases CV, Cerebrovascular Events

Riser patterns in patients' BP resulting from orthostatic hypotension has been linked to increased rates of mortality and major adverse cardiac and cerebrovascular events.

Low-Carbohydrate vs Low-fat Diet Success In Patients With Prediabetes Differs According to Fasting Insulin Levels

Low-Carbohydrate vs Low-fat Diet Success In Patients With Prediabetes Differs According to Fasting Insulin Levels

Fasting plasma glucose, insulin, and insulin sensitivity levels were measured to determine their prognostic value as markers for long-term weight loss.

SPRINT Subanalysis: Intensive SBP Control in Prediabetes vs Normal Fasting Blood Glucose

SPRINT Subanalysis: Intensive SBP Control in Prediabetes vs Normal Fasting Blood Glucose

Researchers conducted a subgroup analysis of the SPRINT clinical trial to determine whether intensive blood pressure treatment outcomes were similar in patients with prediabetes vs normal fasting blood glucose levels.

Sign Up for Free e-Newsletters